Cargando…
The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes
A synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO), has been reported to have anti-inflammatory properties and to decrease the interleukin-1 (IL-1)-induced expression of matrix metalloproteinase-1 (MMP-1) and MMP-13. We have shown previously that IL-1 induces expression of...
Autores principales: | Elliott, Sarah, Hays, Ezra, Mayor, Michael, Sporn, Michael, Vincenti, Matthew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC193729/ https://www.ncbi.nlm.nih.gov/pubmed/12932292 |
Ejemplares similares
-
Matrix Metalloproteinase-9 Production by Immortalized Human Chondrocyte Lines
por: Malemud, Charles J., et al.
Publicado: (2016) -
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection
por: Tran, Thi A, et al.
Publicado: (2008) -
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001) -
Matrix metalloproteinase‐13 unlucky for the forming thrombus
por: Montague, Samantha J., et al.
Publicado: (2018) -
Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)